Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 296

1.

Neuroprotection in Parkinsonian-treated mice via estrogen receptor α activation requires G protein-coupled estrogen receptor 1.

Bourque M, Morissette M, Di Paolo T.

Neuropharmacology. 2015 Aug;95:343-52. doi: 10.1016/j.neuropharm.2015.04.006. Epub 2015 Apr 17.

PMID:
25892506
2.

Implication of GPER1 in neuroprotection in a mouse model of Parkinson's disease.

Bourque M, Morissette M, Côté M, Soulet D, Di Paolo T.

Neurobiol Aging. 2013 Mar;34(3):887-901. doi: 10.1016/j.neurobiolaging.2012.05.022. Epub 2012 Jun 28.

PMID:
22749492
3.

Raloxifene activates G protein-coupled estrogen receptor 1/Akt signaling to protect dopamine neurons in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice.

Bourque M, Morissette M, Di Paolo T.

Neurobiol Aging. 2014 Oct;35(10):2347-56. doi: 10.1016/j.neurobiolaging.2014.03.017. Epub 2014 Mar 20.

PMID:
24726471
4.
5.

Contribution of estrogen receptor subtypes, ERα, ERβ, and GPER1 in rapid estradiol-mediated enhancement of hippocampal synaptic transmission in mice.

Kumar A, Bean LA, Rani A, Jackson T, Foster TC.

Hippocampus. 2015 Dec;25(12):1556-66. doi: 10.1002/hipo.22475. Epub 2015 Jun 12.

6.

Estrogen receptors and gonadal steroids in vulnerability and protection of dopamine neurons in a mouse model of Parkinson's disease.

Al-Sweidi S, Morissette M, Bourque M, Di Paolo T.

Neuropharmacology. 2011 Sep;61(4):583-91. doi: 10.1016/j.neuropharm.2011.04.031. Epub 2011 May 11.

PMID:
21586296
7.

GPER1-mediated immunomodulation and neuroprotection in the myenteric plexus of a mouse model of Parkinson's disease.

Côté M, Bourque M, Poirier AA, Aubé B, Morissette M, Di Paolo T, Soulet D.

Neurobiol Dis. 2015 Oct;82:99-113. doi: 10.1016/j.nbd.2015.05.017. Epub 2015 Jun 4.

PMID:
26051538
8.

Oestrogen receptors and signalling pathways: implications for neuroprotective effects of sex steroids in Parkinson's disease.

Al Sweidi S, Sánchez MG, Bourque M, Morissette M, Dluzen D, Di Paolo T.

J Neuroendocrinol. 2012 Jan;24(1):48-61. doi: 10.1111/j.1365-2826.2011.02193.x. Review.

PMID:
21790809
9.

Telmisartan attenuates MPTP induced dopaminergic degeneration and motor dysfunction through regulation of α-synuclein and neurotrophic factors (BDNF and GDNF) expression in C57BL/6J mice.

Sathiya S, Ranju V, Kalaivani P, Priya RJ, Sumathy H, Sunil AG, Babu CS.

Neuropharmacology. 2013 Oct;73:98-110. doi: 10.1016/j.neuropharm.2013.05.025. Epub 2013 Jun 6.

PMID:
23747572
10.

Estrogen reduces BDNF level, but maintains dopaminergic cell density in the striatum of MPTP mouse model.

Tripanichkul W, Gerdprasert O, Jaroensuppaperch EO.

Int J Neurosci. 2010 Jul;120(7):489-95. doi: 10.3109/00207451003721892.

PMID:
20583901
11.

Estrogen receptors modulate striatal metabotropic receptor type 5 in intact and MPTP male mice model of Parkinson's disease.

Al-Sweidi S, Morissette M, Di Paolo T.

J Steroid Biochem Mol Biol. 2016 Jul;161:84-91. doi: 10.1016/j.jsbmb.2016.02.004. Epub 2016 Feb 9.

PMID:
26873133
13.

G Protein-Coupled Estrogen Receptor 1 Mediates Acute Estrogen-Induced Cardioprotection via MEK/ERK/GSK-3β Pathway after Ischemia/Reperfusion.

Kabir ME, Singh H, Lu R, Olde B, Leeb-Lundberg LM, Bopassa JC.

PLoS One. 2015 Sep 10;10(9):e0135988. doi: 10.1371/journal.pone.0135988. eCollection 2015.

14.

Neuroprotective properties of 17beta-estradiol, progesterone, and raloxifene in MPTP C57Bl/6 mice.

Callier S, Morissette M, Grandbois M, Pélaprat D, Di Paolo T.

Synapse. 2001 Aug;41(2):131-8.

PMID:
11400179
15.

Activation of the G protein-coupled estrogen receptor, but not estrogen receptor α or β, rapidly enhances social learning.

Ervin KS, Mulvale E, Gallagher N, Roussel V, Choleris E.

Psychoneuroendocrinology. 2015 Aug;58:51-66. doi: 10.1016/j.psyneuen.2015.04.002. Epub 2015 Apr 13.

PMID:
25957002
16.

Estrogen receptor α and G-protein coupled receptor 30 mediate the neuroprotective effects of 17β-estradiol in novel murine hippocampal cell models.

Gingerich S, Kim GL, Chalmers JA, Koletar MM, Wang X, Wang Y, Belsham DD.

Neuroscience. 2010 Sep 29;170(1):54-66. doi: 10.1016/j.neuroscience.2010.06.076. Epub 2010 Jul 7.

PMID:
20619320
17.

Signaling pathways mediating the neuroprotective effects of sex steroids and SERMs in Parkinson's disease.

Bourque M, Dluzen DE, Di Paolo T.

Front Neuroendocrinol. 2012 Apr;33(2):169-78. doi: 10.1016/j.yfrne.2012.02.003. Epub 2012 Mar 1. Review.

PMID:
22387674
18.

Effect of estrogen receptor agonists treatment in MPTP mice: evidence of neuroprotection by an ER alpha agonist.

D'Astous M, Morissette M, Di Paolo T.

Neuropharmacology. 2004 Dec;47(8):1180-8.

PMID:
15567427
19.
20.

Supplemental Content

Support Center